Skip to main content

Table 1 Descriptive statistics at baseline by treatment group

From: Capsaicinoids supplementation decreases percent body fat and fat mass: adjustment using covariates in a post hoc analysis

  Capsimax 2 mg Capsimax 4 mg Placebo
Baseline variables
  N Mean ± SD N Mean ± SD N Mean ± SD
 Age 27 31.07 ± 12.02 22 28.86 ± 11.58 28 28.71 ± 10.57
 Height 27 170.13 ± 9.49 22 170.17 ± 8.58 28 173.05 ± 11.11
 Weight 27 79.02 ± 20.12 22 80.16 ± 16.80 28 83.51 ± 19.67
 SBP 27 115.04 ± 14.75 22 117.95 ± 10.28 28 118.89 ± 10.02
 DBP 27 70.22 ± 10.18 22 73.18 ± 8.02 28 72.89 ± 9.64
 BMI 27 27.02 ± 5.88 22 27.42 ± 4.15 28 27.80 ± 6.01
 Waist 25 86.84 ± 17.38 22 89.90 ± 12.44 25 94.58 ± 17.87
 Hip 25 102.44 ± 17.35 22 106.83 ± 10.27 25 107.36 ± 12.85
 WHR 25 0.85 ± 0.06 22 0.84 ± 0.08 25 0.88 ± 0.09
Covariates
 Lean Mass 27 50,234.82 ± 14,130.64 22 52,153.33 ± 12,140.28 28 53,581.51 ± 14,316.47
 Fat Mass 27 20,570.47 ± 11,206.61 22 19,903.67 ± 9337.78 28 20,960.33 ± 11,799.70
 Protein Intake 26 82.52 ± 38.95 22 100.32 ± 68.52 27 88.66 ± 39.97
 Carbohydrate Intake 26 239.61 ± 287.44 22 186.27 ± 70.64 27 188.05 ± 80.82
 Fat Intake 26 66.67 ± 24.71 22 76.99 ± 34.58 27 77.75 ± 45.28
 Serum Total-C 27 173.33 ± 27.97 22 168.36 ± 37.87 28 178.93 ± 42.75
  1. Total-C Total cholesterol; BMI Body mass index; SBP Systolic blood pressure; DBP Diastolic Blood Pressure; WHR Waist Hip Ratio
  2. 1) Main Effect Multivariate p (Wilks’ Lambda) = 0.7073 for Baseline Variables. Univariate Main Effect p-values in all instances were p > 0.05 and ranged from p = 0.3047 to p = 0.8695. 2) Main Effect Multivariate p (Wilks’ Lambda) = 0.0.8562 for Baseline Covariates. Univariate Main Effect p-values in all instances were p > 0.05 and ranged from p = 0.3540 to p = 0.9438. 3) Baseline covariates explained extraneous variance and increased statistical power. Covariates did not dramatically change mean outcomes. There were no baseline differences. 3) N Number of subjects